VBIO (Valion Bio, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Valion Bio, Inc. Common Stock (VBIO) is a publicly traded the market company. As of May 21, 2026, VBIO trades at $0.85 with a market cap of $2.70M and a P/E ratio of 0.00. VBIO moved +0.00% today. Year to date, VBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.80 to $1.21. Rallies surfaces VBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns VBIO stock?
Rallies tracks hedge fund and 13F ownership for VBIO, including fund holders, share counts, and position changes when data is available.
LoConti Joseph E. bought 1.00K (~$200) on Jul 29, 2021.
LoConti Joseph E. bought 13.00K (~$2.60K) on Jul 20, 2021.
LoConti Joseph E. bought 40.00K (~$6.40K) on Jul 19, 2021.
VBIO Analyst Consensus
VBIO analyst coverage data. Average price target: $0.00.
Common questions about VBIO
Who owns VBIO stock?
Rallies tracks hedge fund and 13F ownership for VBIO, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for VBIO?
Yes. Rallies tracks hedge fund and 13F ownership data for VBIO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is VBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VBIO. It does not provide personalized investment advice.
